Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of the Nutritional Supplements: Ultra Q10 and L-carnitine on the Clinical Course of Myelodysplastic Syndrome

NCT02042482 is registered in ClinicalTrials.gov with Kaplan Medical Center as lead sponsor.

NCT NCT02042482
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02042482 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of the Nutritional Supplements: Ultra Q10 and L-carnitine on the Clinical Course of Myelodysplastic Syndrome
Lead sponsor
Kaplan Medical Center
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2013
Completion date
May 31, 2016
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

myelodysplastic syndrome